메뉴 건너뛰기




Volumn 59, Issue 4, 2009, Pages 395-405

Permeation of losartan across human respiratory epithelium: An in vitro study with Calu-3 cells

Author keywords

Calu 3 cells; Losartan; Nasal absorption; Permeation

Indexed keywords

BETA CYCLODEXTRIN; DIMETHYL BETA CYCLODEXTRIN; GLYCOCHOLIC ACID; LOSARTAN; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

EID: 77949476243     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-009-0038-3     Document Type: Article
Times cited : (12)

References (20)
  • 1
    • 34250158434 scopus 로고    scopus 로고
    • Salt, blood pressure and cardiovascular disease
    • DOI: 10.1097/HCO.0b013e32814f1d8c
    • F. He and G. MacGregor, Salt, blood pressure and cardiovascular disease, Curr. Opin. Cardiol. 22 (2007) 298-305; DOI: 10.1097/HCO.0b013e32814f1d8c.
    • (2007) Curr. Opin. Cardiol. , vol.22 , pp. 298-305
    • He, F.1    MacGregor, G.2
  • 3
    • 0029588499 scopus 로고
    • Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans
    • DOI: 10.1016/0009-9236(95)90020-9
    • M. W. Lo, M. R. Goldberg, J. B. McCrea, H. Lu, C. I. Furtek and T. D. Bjornsson, Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans, Clin. Pharmacol. Ther. 58 (1995) 641-649; DOI: 10.1016/0009-9236(95)90020-9.
    • (1995) Clin. Pharmacol. Ther. , vol.58 , pp. 641-649
    • Lo, M.W.1    Goldberg, M.R.2    McCrea, J.B.3    Lu, H.4    Furtek, C.I.5    Bjornsson, T.D.6
  • 4
    • 34248575520 scopus 로고    scopus 로고
    • Intranasal delivery: Physicochemical and therapeutic aspects
    • DOI: 10.1016/j.ijpharm.2007.03.025
    • H. R. Costantino, L. Illum, G. Brandt, P. H. Johnson and S. C. Quay, Intranasal delivery: physicochemical and therapeutic aspects, Int. J. Pharm. 337 (2007) 1-24; DOI: 10.1016/j.ijpharm.2007.03.025.
    • (2007) Int. J. Pharm. , vol.337 , pp. 1-24
    • Costantino, H.R.1    Illum, L.2    Brandt, G.3    Johnson, P.H.4    Quay, S.C.5
  • 5
    • 26644434124 scopus 로고    scopus 로고
    • Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives
    • DOI: 10.1016/j.addr.2005.07.009
    • M. I. Ugwoke, R. U. Agu, N. Verbeke and R. Kinget, Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives, Adv. Drug Deliv. Rev. 57 (2005) 1640-1665, DOI: 10.1016/j.addr.2005.07.009.
    • (2005) Adv. Drug Deliv. Rev. , vol.57 , pp. 1640-1665
    • Ugwoke, M.I.1    Agu, R.U.2    Verbeke, N.3    Kinget, R.4
  • 6
    • 74849091468 scopus 로고    scopus 로고
    • Situ and ex vivo nasal models for preclinical drug development studies
    • (Eds. C. Ehrhardt and K. Kim), AAPS Pharmaceutical Press, New York DOI: 10.1007/978-0-387-74901-3-5
    • R. Agu and M. Ugwoke, In Situ and Ex Vivo Nasal Models for Preclinical Drug Development Studies, in Drug Absorption Studies in Situ, in Vivo and In Silico Models (Eds. C. Ehrhardt and K. Kim), AAPS Pharmaceutical Press, New York 2008, pp. 112-134; DOI: 10.1007/978-0-387-74901-3-5.
    • (2008) Drug Absorption Studies in Situ, in Vivo and in Silico Models , pp. 112-134
    • Agu, R.1    Ugwoke, M.2
  • 7
    • 3242673511 scopus 로고    scopus 로고
    • Cyclodextrins in nasal delivery of low-molecular-weight heparins: In vivo and in vitro studies
    • DOI: 10.1023/B:PHAM.0000032998.84488.7a
    • T. Yang, A. Hussain, J. Paulson, T. J. Abbruscato and F. Ahsan, Cyclodextrins in nasal delivery of low-molecular-weight heparins: in vivo and in vitro studies, Pharm. Res. 21 (2004) 1127-1136; DOI: 10.1023/B:PHAM.0000032998. 84488.7a.
    • (2004) Pharm. Res. , vol.21 , pp. 1127-1136
    • Yang, T.1    Hussain, A.2    Paulson, J.3    Abbruscato, T.J.4    Ahsan, F.5
  • 8
    • 34248674912 scopus 로고    scopus 로고
    • Effects of a sperminated gelatin on the nasal absorption of insulin
    • DOI: 10.1016/j.ijpharm. 2007.02.004
    • T. Seki, H. Kanbayashi, S. Chono, Y. Tabata and K. Morimoto, Effects of a sperminated gelatin on the nasal absorption of insulin, Int. J. Pharm. 338 (2007) 213-218; DOI: 10.1016/j.ijpharm. 2007.02.004.
    • (2007) Int. J. Pharm. , vol.338 , pp. 213-218
    • Seki, T.1    Kanbayashi, H.2    Chono, S.3    Tabata, Y.4    Morimoto, K.5
  • 9
    • 7544236962 scopus 로고    scopus 로고
    • Intranasal delivery of recombinant human parathyroid hormone [hPTH (1-34)] teriparatide in rats
    • DOI: 10.1081/ERC-200035957
    • R. U. Agu, S. Valiveti, D. C. Earles, M. Klausner, P. J. Hayden, D. P. Wermeling and A. L. Stinchcomb, Intranasal delivery of recombinant human parathyroid hormone [hPTH (1-34)], teriparatide in rats, Endocr. Res. 30 (2004) 455-467; DOI: 10.1081/ERC-200035957.
    • (2004) Endocr. Res. , vol.30 , pp. 455-467
    • Agu, R.U.1    Valiveti, S.2    Earles, D.C.3    Klausner, M.4    Hayden, P.J.5    Wermeling, D.P.6    Stinchcomb, A.L.7
  • 10
    • 27644438661 scopus 로고    scopus 로고
    • Comparison of human tracheal/ bronchial epithelial cell culture and bovine nasal respiratory explants for nasal drug transport studies
    • DOI: 10.1002/jps.20404
    • N. V. Chemuturi, P. Hayden, M. Klausner and M. D. Donovan, Comparison of human tracheal/ bronchial epithelial cell culture and bovine nasal respiratory explants for nasal drug transport studies, J. Pharm. Sci. 94 (2005) 1976-1985; DOI: 10.1002/jps.20404.
    • (2005) J. Pharm. Sci. , vol.94 , pp. 1976-1985
    • Chemuturi, N.V.1    Hayden, P.2    Klausner, M.3    Donovan, M.D.4
  • 11
    • 2542448091 scopus 로고    scopus 로고
    • Metabolism and absorption enhancement of methionine enkephalin in human nasal epithelium
    • DOI: 10.1016/j.peptides.2004.02.019
    • R. U. Agu, H. Vu Dang, M. Jorissen, R. Kinget and N. Verbeke, Metabolism and absorption enhancement of methionine enkephalin in human nasal epithelium, Peptides 25 (2004) 563-569; DOI: 10.1016/j.peptides.2004.02.019.
    • (2004) Peptides , vol.25 , pp. 563-569
    • Agu, R.U.1    Vu Dang, H.2    Jorissen, M.3    Kinget, R.4    Verbeke, N.5
  • 13
    • 0034690944 scopus 로고    scopus 로고
    • Determination of plasma concentrations of losartan in patients by HPLC using solid phase extraction and UV detection
    • DOI: 10.1016/S0378-5173(00)00453-1
    • P. K. Yeung, A. Jamieson, G. J. Smith, D. Fice and P. T. Pollak, Determination of plasma concentrations of losartan in patients by HPLC using solid phase extraction and UV detection, Int. J. Pharm. 204 (2000) 17-22; DOI: 10.1016/S0378-5173(00)00453-1.
    • (2000) Int. J. Pharm. , vol.204 , pp. 17-22
    • Yeung, P.K.1    Jamieson, A.2    Smith, G.J.3    Fice, D.4    Pollak, P.T.5
  • 14
    • 0034061961 scopus 로고    scopus 로고
    • Active transport of the angiotensin-II antagonist losartan and its main metabolite EXP 3174 across MDCK-MDR1 and Caco-2 cell monolayers
    • DOI: 10.1038/sj.bjp.0703150
    • A. Soldner, L. Z. Benet, E. Mutschler and U. Christians, Active transport of the angiotensin-II antagonist losartan and its main metabolite EXP 3174 across MDCK-MDR1 and Caco-2 cell monolayers, Br. J. Pharmacol. 129 (2000) 1235-1243; DOI: 10.1038/sj.bjp.0703150.
    • (2000) Br. J. Pharmacol. , vol.129 , pp. 1235-1243
    • Soldner, A.1    Benet, L.Z.2    Mutschler, E.3    Christians, U.4
  • 15
    • 0029865476 scopus 로고    scopus 로고
    • Effects of structural modifications on the intestinal permeability of angiotensin II receptor antagonists and the correlation of in vitro, in situ, and in vivo absorption
    • DOI: 10.1023/A:1016086930019
    • M. D. Ribadeneira, B. J. Aungst, C. J. Eyermann and S. M. Huang, Effects of structural modifications on the intestinal permeability of angiotensin II receptor antagonists and the correlation of in vitro, in situ, and in vivo absorption, Pharm. Res. 13 (1996) 227-233; DOI: 10.1023/A:1016086930019.
    • (1996) Pharm. Res. , vol.13 , pp. 227-233
    • Ribadeneira, M.D.1    Aungst, B.J.2    Eyermann, C.J.3    Huang, S.M.4
  • 16
    • 1542376174 scopus 로고    scopus 로고
    • Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: A comparative analysis in paired tissue specimens
    • DOI: 10.1016/j.clpt.2003.10.008
    • O. von Richter, O. Burk, M. F. Fromm, K. P. Thon, M. Eichelbaum and K. T. Kivistö, Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens, Clin. Pharmacol. Ther. 75 (2004) 172-83; DOI: 10.1016/j.clpt.2003.10. 008.
    • (2004) Clin. Pharmacol. Ther. , vol.75 , pp. 172-183
    • Von Richter, O.1    Burk, O.2    Fromm, M.F.3    Thon, K.P.4    Eichelbaum, M.5    Kivisto, K.T.6
  • 17
    • 0035206717 scopus 로고    scopus 로고
    • Evidence of P-glycoprotein mediated apical to basolateral transport of flunisolide in human broncho-tracheal epithelial cells (Calu-3)
    • DOI: 10.1038/sj.bjp.0704390
    • B. I. Florea, I. C. van der Sandt, S. M. Schrier, K. Kooiman, K. Deryckere, A. G. de Boer, H. E. Junginger and G. Borchard, Evidence of P-glycoprotein mediated apical to basolateral transport of flunisolide in human broncho-tracheal epithelial cells (Calu-3), Br. J. Pharmacol. 134 (2001) 1555-1563; DOI: 10.1038/sj.bjp.0704390.
    • (2001) Br.J. Pharmacol. , vol.134 , pp. 1555-1563
    • Florea, B.I.1    Van Der Sandt, I.C.2    Schrier, S.M.3    Kooiman, K.4    Deryckere, K.5    De Boer, A.G.6    Junginger, H.E.7    Borchard, G.8
  • 19
    • 0026731720 scopus 로고
    • Cyclodextrins as nasal absorption promoters of insulin: Mechanistic evaluations
    • DOI: 10.1023/A:1015847604654
    • Z. Shao, R. Krishnamoorthy and A. K. Mitra, Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations, Pharm. Res. 9 (1992) 1157-1163; DOI: 10.1023/A:1015847604654.
    • (1992) Pharm. Res. , vol.9 , pp. 1157-1163
    • Shao, Z.1    Krishnamoorthy, R.2    Mitra, A.K.3
  • 20
    • 0034945941 scopus 로고    scopus 로고
    • Nasal bioavailability of peptide T in rabbits: Absorption enhancement by sodium glycocholate and glycofurol
    • DOI: 10.1016/S0928-0987(01)00146-4
    • M. A. Bagger, H. W. Nielsen and E. Bechgaard, Nasal bioavailability of peptide T in rabbits: absorption enhancement by sodium glycocholate and glycofurol, Eur. J. Pharm Sci. 14 (2001) 69-74; DOI: 10.1016/S0928-0987(01) 00146-4.
    • (2001) Eur. J. Pharm Sci. , vol.14 , pp. 69-74
    • Bagger, M.A.1    Nielsen, H.W.2    Bechgaard, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.